logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jonathan Kimmelman

mcgill university

46H指数
268论文数
8.8K被引数
收录论文 99
发表时间
logo
Risk–Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis成人实体瘤二线单药治疗试验的风险效益：一项系统评价和Meta分析
errInternational Journal of Cancer
IF4.7
err2026-05-12
err0
errOAAI
errCharlotte Ouimet; Monica Rosu; Jonathan Kimmelman
err分享
err收藏
Drug Approvals in Crowded Drug Classes Potentially Reflect Efficacy Over-Estimates and False Positivity: A Portfolio Analysis of Immune Checkpoint Inhibitor Trials拥挤药物类别中的药物批准可能反映疗效高估和假阳性：一项免疫检查点抑制剂试验的投资组合分析
errJournal of Clinical Epidemiology
IF5.2
err2026-02-13
err0
errOAAI
errBenjamin Gregory Carlisle; Mithat Gönen; Luciano Fernandez; Joseph C. Del Paggio; Jonathan Kimmelman
err分享
err收藏
Early-phase trial efficacy and safety effect estimates regress upon testing in phase 3 trials
errJournal of Clinical Epidemiology
IF5.2
err2026-01-19
err0
errOAAI
errAngela Nelson; Hannah Moyer; Karine Vigneault; Luciano Fernandez; Lily Sefranek; Audrey Mauguen; Jonathan Kimmelman
err分享
err收藏
Evaluating the translational value of preclinical models: Available tools and frameworks, challenges and strategies评估预临床模型的转化价值：可用工具和框架、挑战与策略
errAlternatives to Laboratory Animals
IF0
err2025-11-27
err0
errOAAI
errFrancesca Pistollato; Fabia Furtmann; Marco Straccia; Marc Avey; David Mawufemor Azilagbetor; Celean Camp; Conor Delaney; Guilherme S. Ferreira; Maria Laura Garcia-Bermejo; Annalisa Gastaldello; Kurinchi Gurusamy; Laura Holden; Jonathan Kimmelman; Simon Lohse; Bianca Marigliani; Julia M.L. Menon; Merel Ritskes-Hoitinga; Shaarika Sarasija; Danilo Tagle; Ignacio J. Tripodi; Jan Turner; Martin Wehling; Helder Costantino
err分享
err收藏
Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study权衡开放科学与研究参与负担在知情同意中的关系：一项随机试点研究
errJournal of Empirical Research on Human Research Ethics
IF1.1
err2025-10-01
err0
PREAI
errIskander, Renata; Kane, Patrick; Sharp, Madeleine; Kimmelman, Jonathan
err分享
err收藏
There is no upper limit on the maximum effect that can be detected in randomized trials在随机试验中，可检测到的最大效应没有上限。
errJournal of Clinical Epidemiology
IF5.2
err2025-05-12
err0
errOAAI
errBenjamin Djulbegovic; Iztok Hozo; Renata Iskander; Austin J. Parish; Jonathan Kimmelman; John P.A. Ioannidis
err分享
err收藏
Populations Addressed in Vaccines Approved via the European Medicines Agency通过欧洲药品管理局批准的疫苗所针对的人群
errClinical Pharmacology & Therapeutics
IF5.5
err2025-05-05
err0
errOAAI
errDébora D. Gräf; Lukas Westphal; Jonathan Kimmelman; Christine E. Hallgreen
err分享
err收藏
Supporting evidence in phase 2 cancer trial protocols: a content analysis
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-11-12
err0
errOAAI
errBicer, Selin; Nelson, Angela; Carayannis, Katerina; Kimmelman, Jonathan
err分享
err收藏
Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review综合监管指南，以证明临床前疗效并将有希望的细胞疗法转化为早期临床试验: 范围审查
errBMC MEDICINE
IF8.3
err2024-10-23
err1
errOAAI
errJeffers, Matthew S.; Xi, Cheng En; Bapuji, Raj; Wotherspoon, Hannah; Kimmelman, Jonathan; Bedford, Patrick; McIsaac, Daniel I.; Lalu, Manoj M.; Fergusson, Dean A.
err分享
err收藏
Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care
errMED
IF11.8
err2024-10-01
err1
PREAI
errKimmelman, Jonathan; Kane, Patrick Bodilly; Bicer, Selin; Carlisle, Benjamin Gregory
err分享
err收藏
The Edge of Sentience: Risk and Precaution in Humans, Other Animals, and AI《意识的边缘：人类、其他动物与AI的风险与预防》
errNATURE
IF48.5
err2024-09-23
err0
PREAI
errKimmelman, Jonathan
err分享
err收藏
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development
errNEUROLOGY
IF8.5
err2024-07-09
err0
PREAI
errMoyer, Hannah; Mellett, Robyn; Vigneault, Karine; McKeown, Maya; Karlawish, Jason; Augustine, Erika; Schneider, Lon; Kimmelman, Jonathan
err分享
err收藏
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs: A Systematic Review and Meta-Analysis
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2024-06-25
err5
PREAI
errIskander, Renata; Moyer, Hannah; Vigneault, Karine; Mahmud, Salaheddin M.; Kimmelman, Jonathan
err分享
err收藏
The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials随机试验中接受研究性实体瘤药物的益处和风险
errANNALS OF INTERNAL MEDICINE
IF15.2
err2024-06-01
err1
PREAI
errIskander, Renata; Moyer, Hannah; Fergusson, Dean; McGrath, Sean; Benedetti, Andrea; Kimmelman, Jonathan
err分享
err收藏
Timing for First-in-Minor Clinical Trials of New Cancer Drugs
errJOURNAL OF PEDIATRICS
IF3.5
err2023-12-01
err2
PREAI
errBicer, Selin; Hutchinson, Nora; Feldhake, Emma; Nelson, Angela; Oliviero, Elisabeth; Waligora, Marcin; Kimmelman, Jonathan
err分享
err收藏
Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study
errSCIENTIFIC REPORTS
IF3.9
err2023-09-26
err1
errOAAI
errOuimet, Charlotte; Hutchinson, Nora; Wang, Catherine; Matyka, Carol; Del Paggio, Joseph C.; Kimmelman, Jonathan
err分享
err收藏
Matured forecast analyses for systematic and narrative review lead experts to different cancer trial predictions
errJOURNAL OF CLINICAL EPIDEMIOLOGY
IF5.2
err2023-07-01
err0
PREAI
errYu, Michael; Montroy, Josh; Fergusson, Dean; Lalu, Manoj M.; Kimmelman, Jonathan
err分享
err收藏
Bypassing phase 2 in cancer drug development erodes the risk/benefit balance in phase 3 trials在癌症药物开发中绕过2期会侵蚀3期试验中的风险/收益平衡
errJOURNAL OF CLINICAL EPIDEMIOLOGY
IF5.2
err2023-06-01
err2
PREAI
errMoyer, Hannah; Bittlinger, Merlin; Nelson, Angela; Fernandez, Luciano; Sheng, Jacky; Wang, Yuetong; Del Paggio, Joseph C.; Kimmelman, Jonathan
err分享
err收藏
Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the US Food and Drug Administration A Cross-Sectional Analysis
errANNALS OF INTERNAL MEDICINE
IF15.2
err2022-12-01
err5
PREAI
errAwan, Fareed A.; Becker, Andrew B.; Wang, Yuetong; Kimmelman, Jonathan
err分享
err收藏
Quantifying Patient Investment in Novel Neurological Drug Development
errNEUROTHERAPEUTICS
IF6.9
err2022-09-01
err2
errOAAI
errMacPherson, Amanda; Gumnit, Elias; Ouimet, Charlotte; Hutchinson, Nora; Kieburtz, Karl; Pearson, Toni S.; Kimmelman, Jonathan
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
John P. A. Ioannidis
H 指数: 226 · 论文数: 1.9K
A
Anthony E. Lang
H 指数: 166 · 论文数: 1.6K
M
Mithat Gönen
H 指数: 156 · 论文数: 1.4K
J
Janet Rossant
H 指数: 149 · 论文数: 1.1K
G
George Q. Daley
H 指数: 128 · 论文数: 641
查看更多